Oncology research has been on a 20-year rise and is showing no signs of slowing down anytime in the future. Consider this, between 2000 and 2021, the amount of drugs targeting cancer quadrupled. In 2023, a separate research report found that over 2,000 new oncology clinical trials were launched just that year, and that global spending on cancer medicines “is projected to reach $409 billion by 2028.” Finally, as of May 2025, a search of ClinicalTrials.gov yielded over 39,500 studies indexed under terms including “neoplasm,” “cancer,” and “tumor,” encompassing diverse phases and global locations..

As these trials continue to increase, the traditional models of clinical research are increasingly challenged. Simultaneously, digital transformation has become the new normal in the clinical research landscape.

Learn how digital tools ease oncology research for all stakeholders while accelerating the pace of research with this whitepaper.